PMID: 21931512

Polizzi A, Tesse R, Santostasi T, Diana A, Manca A, Logrillo VP, Cazzato MD, Pantaleo MG, Armenio L
Genotype-phenotype correlation in cystic fibrosis patients bearing [H939R;H949L] allele.
Genet Mol Biol. 2011 Jul;34(3):416-20. Epub 2011 Jul 1., [PubMed]
Sentences
No. Mutations Sentence Comment
3 ABCC7 p.His949Leu
X
ABCC7 p.His949Leu 21931512:3:93
status: NEW
view ABCC7 p.His949Leu details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:3:83
status: NEW
view ABCC7 p.His939Arg details
We ascertained five patients with a novel complex CFTR allele, with two mutations, H939R and H949L, inherited in cis in the same exon of CFTR gene, and one different mutation per patient inherited in trans in a wide population of 289 Caucasian CF subjects from South Italy. Login to comment
17 ABCC7 p.His949Leu
X
ABCC7 p.His949Leu 21931512:17:97
status: NEW
view ABCC7 p.His949Leu details
In 2005, we have described for the first time in the CF mutation database, the missense mutation H949L, a nucleotide change of A to T at base pair 2978 in exon 15 of CFTR gene, resulting in a substitution of histidine residue to leucine at codon 949, as potentially disease-associated allele variation. Login to comment
25 ABCC7 p.His949Leu
X
ABCC7 p.His949Leu 21931512:25:160
status: NEW
view ABCC7 p.His949Leu details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:25:48
status: NEW
view ABCC7 p.His939Arg details
The Cystic Fibrosis Mutation Database lists the H939R missense mutation, a nucleotide substitution of A to G at base pair 2948 in the same exon of the mutation H949L, corresponding to a histidine to arginine amino acid change at codon 939. Login to comment
26 ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:26:105
status: NEW
view ABCC7 p.His939Arg details
The Authors also described the clinical phenothype of the patient, a 17 years old male, with the F508del/H939R genotype, mild expression of a chronic lung disease, pancreatic sufficiency, and unequivocally positive sweat chloride test result. Login to comment
27 ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:27:104
status: NEW
view ABCC7 p.His939Arg details
In this study we evaluated the contribution to the phenotype of the two CF-associated allele mutations [H939R;H949L], combined in cis in the same exon 15 of CFTR gene, which we observed for the first time in 5 unrelated CF patients. Login to comment
43 ABCC7 p.His949Leu
X
ABCC7 p.His949Leu 21931512:43:288
status: NEW
view ABCC7 p.His949Leu details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:43:90
status: NEW
view ABCC7 p.His939Arg details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:43:278
status: NEW
view ABCC7 p.His939Arg details
During the genetic characterization of the 289 enrolled CF patients a new complex allele [H939R;H949L] (Human Genome Variation Society nomenclature c:[2816A>G;2846A>T] http://www.hgvs.org/ mutnomen) was found in five unrelated patients, in whom the two CF-associated mutations, H939R and H949L, were both carried in the exon 15 on the same allele, as showed in Figure 1. Login to comment
45 ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:45:87
status: NEW
view ABCC7 p.His939Arg details
The segregation analysis showed that the mother was the carrier of the complex allele [H939R;H949L] in four cases (patients 2, 3, 4 and 5; Table 1), while only in one case (patient 1) the father carried this complex allele (Table 1). Login to comment
46 ABCC7 p.His949Leu
X
ABCC7 p.His949Leu 21931512:46:50
status: NEW
view ABCC7 p.His949Leu details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:46:37
status: NEW
view ABCC7 p.His939Arg details
We did not find patients bearing the H939R or the H949L mutations alone. Login to comment
47 ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:47:85
status: NEW
view ABCC7 p.His939Arg details
Polizzi et al. 417 Figure 1 - Sequence electropherograms showing the complex allele [H939R;H949L] in CFTR exon 15, (A) forward and (B) reverse (Forward primer: TCAGTAAGTAACTTTGGCTGC; Reverse primer: CCTATTGATGGTGGATCAGC). Login to comment
48 ABCC7 p.His949Leu
X
ABCC7 p.His949Leu 21931512:48:75
status: NEW
view ABCC7 p.His949Leu details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:48:27
status: NEW
view ABCC7 p.His939Arg details
Continuous arrows show the H939R mutation while the dashed arrows show the H949L mutation. Login to comment
56 ABCC7 p.Arg668Cys
X
ABCC7 p.Arg668Cys 21931512:56:311
status: NEW
view ABCC7 p.Arg668Cys details
During our screening analysis we also found thirteen males affected by congenital bilateral absence of vas deferens (CBAVD) bearing the intron 8 (IVS-8) variants TG13-T5 and TG12-T5 in compound heterozygosity with associated CF-causing mutations, and 2 sisters (of 7 and 9 years old respectively) carrying the [R668C;G576A] complex allele in compound heterozygosity with F508del CF mutation, showing a borderline sweat chloride test, recurrent asthmatic bronchitis and pancreatic sufficiency. Login to comment
58 ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:58:37
status: NEW
view ABCC7 p.His939Arg details
To our knowledge the complex allele [H939R;H949L] and its correlation to the CF phenotype were not previously described. Login to comment
59 ABCC7 p.Arg248Thr
X
ABCC7 p.Arg248Thr 21931512:59:36
status: NEW
view ABCC7 p.Arg248Thr details
In the afore mentioned database the R248T mutation that we found in patient 1 was described as "mild", occurring in male patients with CBAVD and no other signs or symptoms, even when associated with another severe mutation. Login to comment
60 ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 21931512:60:86
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21931512:60:69
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:60:146
status: NEW
view ABCC7 p.His939Arg details
The other four patients were compound heterozygotes respectively for G542X, 1259insA, G1349D, F508del and the two associated mutation in exon 15 [H939R;H949L]. Login to comment
61 ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 21931512:61:31
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21931512:61:14
status: NEW
view ABCC7 p.Gly542* details
The mutations G542X, 1259insA, G1349D, F508del have already been described as severe CF-asssociated mutation (Casals et al., 1993; Morral et al., 1993; Morral et al., 1994; Kerem et al., 1995; Estivill et al., 1997; Shrimpton et al., 1997; Rowntree and Harris 2003; Bompadre et al., 2007; Castellani et al., 2008). Login to comment
62 ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 21931512:62:27
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Arg1158*
X
ABCC7 p.Arg1158* 21931512:62:114
status: NEW
view ABCC7 p.Arg1158* details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 21931512:62:125
status: NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Asp579Gly
X
ABCC7 p.Asp579Gly 21931512:62:107
status: NEW
view ABCC7 p.Asp579Gly details
ABCC7 p.Ile502Thr
X
ABCC7 p.Ile502Thr 21931512:62:80
status: NEW
view ABCC7 p.Ile502Thr details
Particularly, 1259insA and G1349D represent with few other mutations, 4382delA, I502T, 852del22, 4016insT, D579G, R1158X and L1077P, almost 20% of the CF alleles found in the Apulian population (Castaldo et al., 2005; Polizzi et al., 2005). Login to comment
64 ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21931512:64:9
status: NEW
view ABCC7 p.Gly542* details
Also the G542X prevents the synthesis of full-length, normal CFTR protein due to the creation of a premature termination codon (Rich et al., 1993; Rowntree and Harris, 2003). Login to comment
65 ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 21931512:65:250
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:65:472
status: NEW
view ABCC7 p.His939Arg details
On the other hand, the F508del mutation, a deletion of three bases encoding a phenylalanine residue at position 508 within the first nucleotide binding domain (NBD), affects CFTR maturation (class II mutations) (Rowntree and Harris, 2003), while the G1349D plays a role in ATP-dependent opening of the chloride channel, resulting in a defective CFTR activation 418 Novel complex allele in CF Table 1 - Clinical features of five unrelated patients with the complex allele [H939R;H949L]. Login to comment
66 ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 21931512:66:130
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21931512:66:115
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg248Thr
X
ABCC7 p.Arg248Thr 21931512:66:109
status: NEW
view ABCC7 p.Arg248Thr details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:66:96
status: NEW
view ABCC7 p.His939Arg details
Patients characteris* Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Mutation in trans with [H939R;H949L] R248T G542X 1259insA G1349D F508del Sex male male male male male Present age (years) 15 15 17 20 25 Age at diagnosis (years) 14 3 0 10 10 Airways colonization No SA SA SA PA, BC Age of first colonization (years) / 9 6 12 14 BMI (kg/m2 ) 21.9 17.0 15.1 17.6 17.5 FEV1 as % predicted 84.4 114.8 80.9 93.2 53.7 Sweat chloride concentration (mEq/L) 78 100 108 92 95 S-K score 100 70 60 75 40 Brasfield scorez N/A 5 11 7 21 Pancreas status PS PI PI PI PI Diagnosis CFTR-RD CF CF CF CF SA = Staphilococcus aureus, PA = Pseudomonas aeruginosa, BC = Burkholderia cepacia; N/A = not applicable; S-K = Shwachman-Kulczycki: the system is based on four parameters (general activity, physical examination, growth and nutrition and chest radiograph x-ray), and is rated as a) excellent: 86-100 b) good: 71-85, c) mild: 56-70, d) moderate: 41-55, and e) severe: < 40 (Shwachman and Kulczyzki, 1958); z scoring system from 3 "mild" to 25 "most severe" (Brett et al., 1992) after x-ray; PS/PI = Pancreatic sufficiency/insufficiency. Login to comment
70 ABCC7 p.His949Leu
X
ABCC7 p.His949Leu 21931512:70:43
status: NEW
view ABCC7 p.His949Leu details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:70:33
status: NEW
view ABCC7 p.His939Arg details
We speculate that both mutations H939R and H949L might affect the second NBD of CFTR and have a role in altering the conductance of the chloride channel, but to our knowledge there are no reports on their functions. Login to comment
71 ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 21931512:71:137
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21931512:71:120
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:71:61
status: NEW
view ABCC7 p.His939Arg details
In our study, the four patients carrying the complex allele [H939R;H949L] associated in trans with the severe mutations G542X, 1259insA, G1349D and F508del presented the classic CF phenotype. Login to comment
72 ABCC7 p.Arg248Thr
X
ABCC7 p.Arg248Thr 21931512:72:72
status: NEW
view ABCC7 p.Arg248Thr details
On the contrary, patient 1 who carried the same complex allele with the R248T mutation showed a CFTR-RD (Table 1). Login to comment
73 ABCC7 p.Arg248Thr
X
ABCC7 p.Arg248Thr 21931512:73:36
status: NEW
view ABCC7 p.Arg248Thr details
This is likely due to the fact that R248T is a mild mutation (thought to affect CFTR mRNA splicing based on the database: Cystic Fibrosis Mutation Database), and subjects carrying this mutation might have a residual function of the CFTR protein. Login to comment
74 ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:74:34
status: NEW
view ABCC7 p.His939Arg details
It seems that the complex allele [H939R;H949L] greatly reduces the residual function of CFTR and, when also on the other allele is present a severe mutation which produces a very low residual function, the combined effect is an overall great reduction of CFTR functionality; on the contrary, when the other allele carries a mild mutation, the overall effect is a cumulative greater CFTR functionality. Login to comment
75 ABCC7 p.Arg668Cys
X
ABCC7 p.Arg668Cys 21931512:75:224
status: NEW
view ABCC7 p.Arg668Cys details
We also found in our CF population subjects carrying the variant tracts TG13-T5 and TG12-T5, which have been already described in males with CBAVD in the literature (Castellani et al., 2008; Dequeker et al., 2009), and the [R668C;G576A] complex allele. Login to comment
76 ABCC7 p.Arg668Cys
X
ABCC7 p.Arg668Cys 21931512:76:4
status: NEW
view ABCC7 p.Arg668Cys details
ABCC7 p.Gly576Ala
X
ABCC7 p.Gly576Ala 21931512:76:84
status: NEW
view ABCC7 p.Gly576Ala details
The R668C in exon 13 is considered a polymorphism (Pignatti et al., 1994) while the G576A, in CFTR exon 12, seems to induce a variable extent of exon skipping that leads to reduced levels of normal CFTR transcripts (Pagani et al., 2003). Login to comment
77 ABCC7 p.His949Leu
X
ABCC7 p.His949Leu 21931512:77:220
status: NEW
view ABCC7 p.His949Leu details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:77:183
status: NEW
view ABCC7 p.His939Arg details
ABCC7 p.His939Arg
X
ABCC7 p.His939Arg 21931512:77:206
status: NEW
view ABCC7 p.His939Arg details
The complex alleles and their role in disease pathogenesis still remain a challenge for both researchers and clinicians, thus more information on our newly discovered complex allele [H939R;H949L] or on the H939R and the H949L mutations alone would help to study the effect on the phenotype of these rare mutations. Login to comment